Vitamin D and neuralgia in multiple myeloma
- Conditions
- Peripheral neuropathy - perifere neuropathieMultiple myeloma - multipel myeloomVitamin D - vitamine D
- Registration Number
- NL-OMON27690
- Lead Sponsor
- Medical Centre Leeuwarden
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
Patients with smoldering or symptomatic multiple myeloma
Patients 18 years or older
Exclusion Criteria
None
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The correlation between PN and the vitamin D status in MM patients.
- Secondary Outcome Measures
Name Time Method - to evaluate the influence of vitamin D on the severity of PN<br /><br><br>- to determine the correspondence of the ICPNQ results and patients’ records.<br /><br><br>- the number of patients with low 25-hydroxyvitamin D serum levels<br /><br> <br>- to search for differences in incidence of PN for each drug<br>